UBX0101 (MDM2 inhibitor, Unity Biotechnology) targeted p53-MDM2 interaction in senescent cellsPhase 2 for knee OA failed in 2020
While they might seem like a convenient or cheaper alternative, especially during times of high demand, these products carry significant risks
and quinones and semiquinones, which are intermediates of melanin biosynthesis, are mutagenic with the capacity to cause cytogenetic instability
These drugs were initially developed for the treatment and/or management of diabetes, but scientists thought this drug could be a direct cure for obesity as well
Click here to view the current Top 50 rankings
The Genetic Basis of GLP-1 Resistance Recent studies conducted by researchers affiliated with Stanford Medicine identified variants within the GLP1R gene, which encodes the GLP-1 receptor targeted by semaglutide and related therapies